CEM introduces a breakthrough new technology of microwave peptide synthesis

Matthews, NC June 24, 2013 / AP / -- CEM Corporation, a leading global supplier of microwave test instruments, is pleased to announce a new series of products that can significantly change the peptide synthesis paradigm found early in preclinical research The research scale microwave peptide synthesis system of liberty blue? Series and the medium-sized microwave peptide synthesis system of liberty XL? Were favored by the participants at the 23rd American peptide Symposium in Hawaii on Sunday, June 23 Liberty blue technology allows a cycle time of four minutes, and the amount of solvent used is 90% less than the existing peptide preparation method The technology significantly improves hardware design and chemical processes, resulting in higher speed and flexibility, peptide purity and yield, and stability Michael J Collins, President and CEO of CEM Corporation, said: "this is a revolutionary technology that will completely change the field of peptide synthesis It will provide the unprecedented ability of peptide synthesis in the whole process, from the lead optimization of the generation of Mg amount to the establishment of the target peptide library, to the production of 200g amount for pre clinical research " Collins continued: "the cycle is 10 times faster than the current microwave synthesis, allowing pharmacists to make normal peptides in less than an hour In addition, the purity of the peptides generated by these new microwave peptide synthesis systems is still unparalleled, even if the cycle is accelerated " The patent pending flex add? Technology of the system provides infinite delivery with high accuracy and precision, which enables the liberty blue series to cover a large-scale range of 0.025-5 mmol, and is the largest research scope of all microwave peptide synthesis systems In addition, the chemical process can be directly upgraded to 100 mmol through the new liberty XL Liberty blue series microwave peptide synthesis system focuses on achieving the highest speed, efficiency and ease of use, including manual, automatic and high flux systems, and liberty XL is a medium-sized automatic system [4.76%] These systems all use the patented technology of microwave energy, which is connected and deprotected in the synthesis process of CEM, to ensure that higher purity and output can be obtained faster than before Collins concluded: "we expect liberty blue and liberty XL to have a greater impact on peptide synthesis than when we first launched microwave peptide technology, which has become the choice of many researchers These new products will give pharmacists another chance to break through the restriction of peptide synthesis " CEM Corporation, headquartered in Matthews, North Carolina, USA, is a leading global company focused on key experimental application science solutions The company has branches in the UK and Ireland, Germany, Italy, France and Japan, as well as a global distributor network CEM designs and manufactures systems for bioscience applications, life sciences, analytical laboratories, and processing plants worldwide The company's products are used in many industries, including pharmaceuticals, biotechnology, chemical and food processing, as well as academic research.